ATE194360T1 - Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen - Google Patents

Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen

Info

Publication number
ATE194360T1
ATE194360T1 AT94926448T AT94926448T ATE194360T1 AT E194360 T1 ATE194360 T1 AT E194360T1 AT 94926448 T AT94926448 T AT 94926448T AT 94926448 T AT94926448 T AT 94926448T AT E194360 T1 ATE194360 T1 AT E194360T1
Authority
AT
Austria
Prior art keywords
pct
inhibitors
binding proteins
producing binding
proteinases
Prior art date
Application number
AT94926448T
Other languages
English (en)
Inventor
Bengt Guss
Hans Jonsson
Martin Linberg
Hans-Peter Mueller
Liisa K Rantamaeki
Original Assignee
Bengt Guss
Hans Jonsson
Martin Linberg
Mueller Hans Peter
Liisa K Rantamaeki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Guss, Hans Jonsson, Martin Linberg, Mueller Hans Peter, Liisa K Rantamaeki filed Critical Bengt Guss
Application granted granted Critical
Publication of ATE194360T1 publication Critical patent/ATE194360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT94926448T 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen ATE194360T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302855A SE9302855D0 (sv) 1993-09-06 1993-09-06 Method and means for producing plasmaproteinase inhibitor binding proteins
PCT/SE1994/000826 WO1995007296A1 (en) 1993-09-06 1994-09-06 Method and means for producing plasmaproteinase inhibitor-binding proteins

Publications (1)

Publication Number Publication Date
ATE194360T1 true ATE194360T1 (de) 2000-07-15

Family

ID=20390977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94926448T ATE194360T1 (de) 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen

Country Status (9)

Country Link
US (1) US6100055A (de)
EP (1) EP0724596B1 (de)
AT (1) ATE194360T1 (de)
AU (1) AU7628194A (de)
CA (1) CA2176230A1 (de)
DE (1) DE69425149T2 (de)
ES (1) ES2149884T3 (de)
SE (1) SE9302855D0 (de)
WO (1) WO1995007296A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9823975D0 (en) * 1998-11-02 1998-12-30 Actinova Ltd Protein
US6740322B2 (en) * 2000-06-12 2004-05-25 University Of Saskatchewan Immunization of dairy cattle with Mig protein
PL365246A1 (en) * 2000-09-25 2004-12-27 Societe Des Produits Nestle S.A. Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
ATE471156T1 (de) 2002-10-11 2010-07-15 Bengt Guss Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
EP2227249B1 (de) 2007-12-13 2018-04-25 Intervacc AB Verbesserte immunisierende zusammensetzung
EP3135684B1 (de) 2010-05-26 2023-06-28 Intervacc AB Impfstoff gegen streptokokkeninfektionen auf der basis von rekombinanten fusionsproteinen
EP3604341A4 (de) * 2017-03-31 2020-12-09 Kaneka Corporation Affinitätsdissoziationsmatrix für immunglobulin-reinigungszwecke
RU2758604C2 (ru) * 2019-12-10 2021-11-01 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Рекомбинантный белок GM, обладающий способностью связывать α2-макроглобулин и его применение в качестве лиганда в аффинной хроматографии для выделения α2-макроглобулина из сыворотки крови человека

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins

Also Published As

Publication number Publication date
ES2149884T3 (es) 2000-11-16
EP0724596B1 (de) 2000-07-05
WO1995007296A1 (en) 1995-03-16
CA2176230A1 (en) 1995-03-16
SE9302855D0 (sv) 1993-09-06
US6100055A (en) 2000-08-08
EP0724596A1 (de) 1996-08-07
DE69425149D1 (de) 2000-08-10
DE69425149T2 (de) 2001-03-15
AU7628194A (en) 1995-03-27

Similar Documents

Publication Publication Date Title
ATE412749T1 (de) Chemisch modifizierter gewebeinhibitor für metalloproteasen type 3 (timp-3)
ATE193542T1 (de) Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren
ATE224713T1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
DE69425267D1 (de) 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
ATE318903T1 (de) Modulatoren für die regenerierung von gewebe
FI965031A (fi) Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni
DE69727142D1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
SE8902532D0 (sv) Bestaemning av plasmaproteiner
ATE240743T1 (de) Verfahren und substanzen gegen protozoen
ATE194360T1 (de) Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
DE59503269D1 (de) Verfahren zur bearbeitung von nukleinsäuren
DE69433243D1 (de) Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
EP1385993B8 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE69605946D1 (de) Verfahren und vorrichtung zum schleifen insbesondere von brammen
DE59402209D1 (de) Verfahren zum dreiseitigen Beschneiden von Stapeln aus Buchblocks, Broschüren o. dgl. und Schneidemaschine zum Durchführen des Verfahrens
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
HU9303318D0 (en) New 2-saccharinyl-methyl-phosphates, and phosphinates, their use as proteolytic enzime inhibitors, process for producing them, and preparations containing them
DE69739263D1 (de) Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten
DK0651764T3 (da) Cytotoksisk T-lymfocytantigen som cysteinproteaseinhibitor
EP1416048A4 (de) An der bildung einer in exon 5 defekten spleissvariante des presenilin-2-gens beteiligte nukleinsäure
DE59611353D1 (de) Transketolase-verwandtes protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties